# Passage BIO, Inc.: Form DEF 14A, filed Apr 7, 2026

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: DEF 14A
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 07:00 ET
- Period: 2026-05-19
- Accession: 0001104659-26-040130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000110465926040130/pasg-20260519xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000110465926040130/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000110465926040130/pasg-20260519xdef14a.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-040130. Last ingested by Listed: Nov 6, 2026, 11:01 ET. No prices; not investment advice.